Home
>
National Drug Code (NDC)
>
BENZONATATE
BENZONATATE - 57664-134-13 - (BENZONATATE)
Drug Information of BENZONATATE
| Product NDC: | 57664-134 |
| Proprietary Name: | BENZONATATE |
| Non Proprietary Name: | BENZONATATE |
| Active Ingredient(s): | 200 mg/1 & nbsp; BENZONATATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BENZONATATE
| Product NDC: | 57664-134 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040587 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080407 |
Package Information of BENZONATATE
| Package NDC: | 57664-134-13 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (57664-134-13) |
NDC Information of BENZONATATE
| NDC Code | 57664-134-13 |
| Proprietary Name | BENZONATATE |
| Package Description | 500 CAPSULE in 1 BOTTLE (57664-134-13) |
| Product NDC | 57664-134 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BENZONATATE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080407 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | BENZONATATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |
